Hip FractureNCT07908836
PBM and Hip Fracture
An observational study of Hip Fracture, run by Hospital del Rio Hortega at 1 site in Spain.
Trial summary
The main objective of this study was to describe the application of PBM strategies in patients undergoing surgery for hip fractures, their outcomes between 2022 and 2024, and the factors associated with the transfusion of red blood cell concentrates. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Hip Fracture
- How many people
- 829 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jan 2022to 30 May 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: adult patients admitted for a hip fracture
Who may be able to join
- Adult patients admitted for a hip fracture And Surgical treatment between January 2022 and April 2024
Who cannot join
- Pathological fractures secondary to neoplasia,
- High-energy fractures in young patients,
- Records lacking sufficient information for the main analyses
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Management of the Patient's Blood in Patients With Hip Fractures: a Retrospective Cohort Study
The main objective of this study was to describe the application of PBM strategies in patients undergoing surgery for hip fractures, their outcomes between 2022 and 2024, and the factors associated with the transfusion of red blood cell concentrates. As secondary objectives, the study analysed the factors associated with surgical delay, particularly prior oral anticoagulation, as well as post-operative delirium, in-hospital complications, prolonged hospital stay and mortality at 30 days, 6 months and 1 year.
Translated with DeepL.com (free version)
- Conditions
- Hip Fracture
- Keywords
- PBM, Mortality
- Medical subject headings
- Hip Fractures
What is being measured
The primary outcome is the main question the study is designed to answer.
Application of PBM strategies in patients who have undergone surgery for a hip fracture
Specification for the application of the PBM pillars during hospital admission.
Measured: length of hospital stay
Secondary outcomes (3)
post-operative delirium
Episode of delirium documented in the hospital medical record
Measured: hospital admission
in-hospital complications
Measured: hospital admission
mortality
Measured: at 30 days, 6 months and 1 year.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2026
- Study start1 Jan 2022
- Primary completion30 May 2024
- Study completion30 May 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hip FractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 829 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital del Rio Hortega
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Cesar Aldecoa, Hospital del Rio Hortega
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07908836
- Sponsor's protocol ID
- PI-24-195-H
- Status last verified
- Oct 2026
- First submitted
- 22 Oct 2026
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: a single-centre retrospective study to be published
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Management of the Patient's Blood in Patients With Hip Fractures: a Retrospective Cohort Study
- ClinicalTrials.gov ID
- NCT07908836
- Acronym / sponsor ID
- PI-24-195-H
- Conditions
- Hip Fracture
- Keywords
- PBM, Mortality
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 829 participants (actual)
- Lead sponsor
- Hospital del Rio HortegaUniversity, hospital or other
- Study start
- 1 Jan 2022 (actual)
- Primary completion
- 30 May 2024 (actual)
- Study completion
- 30 May 2024 (actual)
- First posted
- 2 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective of this study was to describe the application of PBM strategies in patients undergoing surgery for hip fractures, their outcomes between 2022 and 2024, and the factors associated with the transfusion of red blood cell concentrates. As secondary objectives, the study analysed the factors associated with surgical delay, particularly prior oral anticoagulation, as well as post-operative delirium, in-hospital complications, prolonged hospital stay and mortality at 30 days, 6 months and 1 year.
Translated with DeepL.com (free version)
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- adult patients admitted for a hip fracture
Key inclusion criteria (1 listed)
- Adult patients admitted for a hip fracture And Surgical treatment between January 2022 and April 2024
Key exclusion criteria (3 listed)
- Pathological fractures secondary to neoplasia,
- High-energy fractures in young patients,
- Records lacking sufficient information for the main analyses
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Application of PBM strategies in patients who have undergone surgery for a hip fracture
Time frame: length of hospital stay
Specification for the application of the PBM pillars during hospital admission.
3 secondary outcomes
post-operative delirium
Time frame: hospital admission
in-hospital complications
Time frame: hospital admission
mortality
Time frame: at 30 days, 6 months and 1 year.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- Individual participant dataSharing planned: No. a single-centre retrospective study to be published
Related trials for Hip Fracture
RecruitingObservational study
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Fracture; Pelvic, Insufficiency Fractures
Not yet recruiting
A Decision Support Tool for Common Surgical Fixations of Hip Fractures
Hip Fracture Surgeries, High Risk Population of Hip Fractures
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Enrolling by invitationObservational study
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Osteoporosis
Recruiting
Monitored Anesthesia Care and Soft Tissue Infiltration With Local Anesthesia Feasibility Trial
Hip Fracture Surgeries, Intertrochanteric Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hip Fracture, run by Hospital del Rio Hortega at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Application of PBM strategies in patients who have undergone surgery for a hip fracture (time frame: length of hospital stay). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.